Antimicrobial Susceptibility Testing Using High Surface-to-Volume Ratio Microchannels

Antimicrobial susceptibility testing using high surface-to-volume ratio microchannels.

This study reports the use of microfluidics, which intrinsically has a large surface-to-volume ratio, toward rapid antimicrobial susceptibility testing at the point of care. By observing the growth of uropathogenic Escherichia coli in gas permeable polymeric microchannels with different dimensions, we demonstrate that the large surface-to-volume ratio of microfluidic systems facilitates rapid g...

High-throughput microarray for antimicrobial susceptibility testing

We describe the development of a novel, high-throughput, nano-scale microarray platform for antimicrobial susceptibility testing (AST). The platform allows to process 480 samples at 50 nL volume on a single chip, analyze by fluorescence read-out with an easy dunk-and-rinse step, and the ability to process multiple samples and chips simultaneously. We demonstrate the applicability of this chip f...

Single cell antimicrobial susceptibility testing by confined microchannels and electrokinetic loading.

Multidrug-resistant pathogens are an emerging global health problem. In addition to the need of developing new antibiotics in the pipeline, the ability to rapidly determine the antibiotic resistance profiles of bacteria represents one of the most crucial steps toward the management of infectious diseases and the prevention of multidrug-resistant pathogens. Here, we report a single cell antimicr...

Antimicrobial susceptibility testing issues relating to EARSS

Surface-to-volume ratio with oscillating gradients.

Restrictions to diffusion result in the dispersion of the bulk diffusion coefficient. We derive the exact universal high-frequency behavior of the diffusion coefficient in terms of the surface-to-volume ratio of the restrictions. This frequency dependence can be applied to quantify structure of complex samples with NMR using oscillating field gradients and static-gradient CPMG. We also demonstr...